CMS Francis Lefebvre's Bertrand Sénéchal brings a wealth of experience advising issuers and investors on small to mid-cap transactions surrounding the sale of shares, private placements, and investments in companies often listed on Euronext’s regulated Market. The team also advises on unsolicited tender offers.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Availability. Proactive approach. Solution finder.'
- ‘Bertrand Sénéchal is proactive, knowledgeable, experienced, and pragmatic.'
- ‘Responsiveness, availability, adaptability. In addition to technical expertise, an excellent understanding of market practices.’
Key clients
- Capital B
- Genfit
- GenSight
- INNATE PHARMA
- Lhyfe
- NHOA
- Transgene
Work highlights
Advised Capital B on the set-up of an “ATM-like” programme by Capital B, a French Bitcoin treasury company listed on Euronext Growth.
Advised Citadel LLC on its investment into DBV Technologies, a French biotech company listed on the regulated Market of Euronext in Paris and on NASDAQ.
Advised GenSight, a French biotech company listed on the regulated market of Euronext in Paris.
Practice head
Bertrand Sénéchal